U.S. Agency Seeks Reexamination Of Biotech Patent
In its filing, the Department of HHS argues that the patent, filed in November 2001, was anticipated by another patent filed in September 1993 by the Department of HHS.
The patent, U.S. patent no. 6,653,104, is for “immunotoxins, comprising an internalizing...
To view the full article, register now.